[go: up one dir, main page]

Zhang et al., 2005 - Google Patents

PROSPECTIVE IDENTIFICATION OF ADULT PANCREATIC STEM/PROGENITOR CELLS

Zhang et al., 2005

Document ID
368548181760424856
Author
Zhang L
Heidt D
Simeone D
Burant C
Publication year
Publication venue
Pancreas

External Links

Snippet

Background: Multipotent pancreatic precursor cells have been isolated clonally, however, stem/progenitor cells which displays both self-renewal and multipotency have not been prospectively identified in adult pancreatic tissue. Results: We developed an in vitro culture …
Continue reading at journals.lww.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Similar Documents

Publication Publication Date Title
Chari et al. Autoimmune pancreatitis: diagnosis using histology, imaging, serology, other organ involvement and response to steroids
Ewald et al. Pancreas divisum: An underestimated cause of chronic pancreatitis and relapsing episodes of acute pancreatitis?
Neri et al. Hemoconcentration as an early marker of severity of acute pancreatitis
Farrell et al. Endoscopic ultrasound fine needle injection (EUS-FNI) of a novel gene transfer therapy against pancreatic cancer: a single institution experience
Bluth et al. Pancreatitic serum induces morphological changes in macrophages
Lin et al. Linear siRNA mediated gene knockdown of pancreatitis-associated protein (PAP) in cellular pancreatitis
Aghdassi et al. Depletion of Heat Shock Protein-70 (Hsp70) Causes Apoptosis in Pancreatic Cancer Cells
Garber et al. AUTOIMMUNE PANCREATITIS META-ANALYSIS: TIME FOR A SINGLE NOMENCLATURE?
Grippo et al. Loss of pigment epithelium-derived factor (PEDF) expression enhances pancreatic intraepithelial neoplasia (PanIN) frequency and pancreatic fibrosis in vivo
Schmidt et al. PHASE III TRIAL CAPRI (ADJUVANT CHEMORADIOIMMUNOTHERAPY OF PANCREATIC ADENOCARCINOMA) VERSUS 5-FU ALONE
Jakobovits et al. AGS-PSCA: a fully human antibody to PSCA for the treatment of pancreatic cancer
Hatori et al. Carcinoma In Situ Of The Pancreas: 3 Case Reports
Chen et al. A proteomics analysis of pancreatic zymogen granule membranes
Tashiro et al. Nationwide epidemiological survey of chronic pancreatitis in Japan
Fernandez-Zapico et al. GLOBAL FUNCTIONAL ANALYSIS OF SP/KLF PROTEINS IDENTIFY KLF11 AS NOVEL TUMOR SUPPRESSOR CANDIDATE FOR PANCREATIC CANCER
Zhang et al. PROSPECTIVE IDENTIFICATION OF ADULT PANCREATIC STEM/PROGENITOR CELLS
Lu et al. A SYSTEMATIC REVIEW OF CYTOTOXIC TREATMENT OF PANCREATIC CANCER 1977-2004
Murphy et al. BILE SENSITIZES INOSITOL TRISPHOSPHATE AND RYANODINE RECEPTORS TO EXCESSIVE CALCIUM RELEASE IN MOUSE PANCREATIC ACINAR CELLS
Strobel et al. TUBULAR COMPLEXES ARE NOT OF β-CELL ORIGIN: GENETIC LINEAGE TRACING IN A MOUSE MODEL OF PANCREATITIS
Edderkaoui et al. IGF-R MEDIATES THE FIBRONECTIN-INDUCED PROTECTION FROM APOPTOSIS IN PANCREATIC CANCER CELLS
Morris et al. ACTIVATION OF PAR1 AND PAR2 RESULTS IN CALCIUM AND MAP KINASE DEPENDENT PROLIFERATION OF PANCREATIC TUMOR CELLS
Kleinhans et al. EFFECT OF THE BOVINE HEMOGLOBIN SOLUTION (HBOC-301) WITH AND WITHOUT ISOVOLEMIC HEMODILUTION ON PANCREATIC TISSUE OXYGENATION, PANCREATIC MICROCIRCULATION AND SURVIVAL IN PIGS WITH SEVERE ACUTE PANCREATITIS
Orchekowski et al. SERUM-PROTEIN ALTERATIONS IN PANCREATIC CANCER PATIENTS AND THEIR USE FOR DISEASE CLASSIFICATION
Wang et al. INHIBITION OF NUCLEAR FACTOR κB ACTIVATION IN BXPC-3 CELLS BY GENISTEIN IS MEDIATED VIA NOTCH-1 SIGNALING PATHWAY
Husain et al. DISTINCT CALCIUM SIGNALS REGULATE PANCREATIC ZYMOGEN ACTIVATION